The short version
If you can get aroused and stay erect but cannot reach ejaculation or orgasm with a partner, start with your GP. Delayed ejaculation (DE) has medical causes that are worth checking first: medicines, thyroid or hormone problems, diabetes, nerve damage and prostate treatment among them. Do not stop or change any prescribed medicine on your own; any adjustment is a conversation with the prescriber. Chest pain, faintness or breathlessness is an emergency: call 000 (Australia), 999 (UK) or 911 (US).
DE is uncommon, it is under-researched, and it is not usually anyone's fault (a general clinical observation). The usual pattern is that a man ejaculates easily alone and with great difficulty, or not at all, with a partner. Some contributing factors can be changed, but the treatment evidence is thin, and this guide says so. Evidence strength is labelled STRONG, MODERATE, EMERGING, CONTESTED or UNEVIDENCED. Breath, somatic and mindfulness practices appear here only as a possible adjunct, argued at the level of mechanism, with no direct trials found for DE. This is educational information, not individual medical advice.
What delayed ejaculation means, and how rare it is
Clinicians do not agree on one definition. In a 2018 review, Abdel-Hamid and Ali set out the main ones. The DSM-5 describes a marked delay in ejaculation, or a marked infrequency or absence of ejaculation, on 75 to 100 per cent of occasions for at least six months of partnered sexual activity, without the man wanting the delay, and causing significant distress. The Third International Consultation on Sexual Medicine used a time threshold, ejaculation taking longer than about 20 to 25 minutes of sexual activity, plus bother or distress. Perelman has criticised that cut-off, noting that most men's ejaculation latency sits around 4 to 10 minutes, and has proposed about 10 minutes. The review adds that no gold standard for diagnosis exists.
Two pairs of labels are used. Lifelong DE has been present since a man's first sexual experiences; acquired DE starts after a period of normal function. Generalised DE happens in all circumstances, including alone; situational DE happens only in some, most often with a partner. Perelman (2016) describes the typical situational presentation as difficulty or inability to ejaculate with a partner, especially during intercourse, with little difficulty alone.
On how common it is, the numbers depend on the definition. Abdel-Hamid and Ali report a prevalence of about 1 per cent of sexually active men for lifelong DE and up to about 5 per cent for acquired DE, and Perelman (2016) gives 1 to 4 per cent. Abdel-Hamid and Ali describe DE as the least common of the male sexual dysfunctions and say the lack of a universal definition limits what is known. Treat all of these as rough estimates. Evidence label for the prevalence figures: EMERGING.
Why it happens: causes and how strong the evidence is
The reviews agree that DE is multifactorial, with organic and psychological factors that overlap rather than compete. Abdel-Hamid and Ali add that many proposed causes rest on case reports and case series rather than good data. Taking the causes in turn:
Medicines. This is the most practical cause to check. Abdel-Hamid and Ali list antidepressants (SSRIs, tricyclics, MAOIs), antipsychotics, some blood-pressure medicines, alpha-blockers, opioids, antiepileptics, 5-alpha reductase inhibitors and alcohol among agents associated with DE. They report that DE or anejaculation is the most commonly reported sexual problem with antidepressants, and cite a study with roughly a sevenfold higher risk in SSRI users. Nguyen and colleagues (2024) report wide ranges of delayed orgasm across individual antidepressants, which shows how variable the effect is. Perelman (2016) cautions that depression itself may reduce orgasmic capacity more than antidepressant side effects do. Evidence label: MODERATE that these medicines can delay ejaculation; the risk for any one person is uncertain. Do not stop an antidepressant because of this; untreated depression carries its own risks.
Hormones. Abdel-Hamid and Ali report that hypothyroidism has been strongly associated with longer ejaculation latency. For testosterone the picture is mixed: one randomised trial found no significant DE improvement with a testosterone solution in androgen-deficient men, while a company-sponsored trial reported improved ejaculatory function in hypogonadal men (ejaculatory dysfunction was not an entry criterion). The link with raised prolactin is described as weak. Evidence label: MODERATE for thyroid, CONTESTED for testosterone and prolactin.
Nerves, diabetes and surgery. Anything that damages the nerves that control ejaculation can cause DE or absent ejaculation. The review reports DE or anejaculation in up to 17.9 per cent of men with multiple sclerosis, and notes that 52 per cent of men with spinal cord injury cannot ejaculate during intercourse. In a population-based study it cites, inability to reach orgasm with masturbation was slightly more common in men with diabetes (21.1 per cent) than without (14.9 per cent), though the true incidence in diabetes is unclear. After high-dose prostate cancer radiotherapy, 40 per cent of 109 men reported DE and 11 per cent anejaculation, and radical pelvic surgery can injure the structures involved. Evidence label: STRONG that nerve injury, pelvic surgery and radiotherapy can impair ejaculation; frequency varies by condition.
Psychological and behavioural factors. Althof, as summarised by Abdel-Hamid and Ali, grouped the proposed psychological explanations into four theories. First, insufficient mental or physical stimulation, supported by findings that men with DE and no apparent physical cause report lower arousal. Second, unusual masturbation patterns. Third, a disguised desire problem, in which a man mainly prefers solo sex. Fourth, unresolved conflict such as fear, hostility or guilt. Perelman (2016) adds that anxiety pulls attention away from erotic cues, so that stimulation is not enough for climax even when the erection holds, and that intrusive self-monitoring during sex (often called spectatoring) has long been proposed as a factor. Evidence label: MODERATE that stimulation and attention matter; EMERGING for most of the specific psychodynamic explanations, which rest on clinical observation rather than controlled study.
Masturbation style. Perelman and Rowland identified three factors that were more common in men with DE: frequent masturbation (an age-dependent average of more than about three times a week), an idiosyncratic style that partnered sex cannot easily reproduce, and a gap between the reality of partnered sex and the fantasy used alone. Bronner and Ben-Zion (2014) described four young men whose unusual masturbatory practices were linked to sexual dysfunction, and found that unlearning the practices contributed notably to improvement. Four cases is a very small base. The popular term "death grip" is slang, not a clinical diagnosis, and none of the sources cited here uses it. Evidence label: EMERGING, from clinical observation and case series.
Pornography. It is common to hear that pornography causes DE. The 2024 review by Nguyen and colleagues states that no studies have identified an association between orgasmic dysfunction and pornography use. A mismatch between what arouses a man alone and what a partner's body and pacing provide is a plausible mechanism, and it falls under the fantasy-gap factor above, but a causal link from pornography itself is UNEVIDENCED.
Medical first: what a GP assessment involves
Abdel-Hamid and Ali conclude that the history is the key to diagnosis. A GP will usually ask when it started, whether it happens alone, with a partner or both, whether erections are reliable, and about alcohol, medicines and stress. The reviews describe a focused examination and, where indicated, blood tests, with the aim of excluding other problems that can look like DE, such as retrograde ejaculation (where semen goes back into the bladder), erectile dysfunction, low desire, pain with ejaculation, or the partner's own sexual difficulty.
A GP may refer to a urologist or endocrinologist when something specific turns up: a hormone abnormality, neurological signs, a history of pelvic surgery or radiotherapy, or a problem with the genital tract. A psychologist or sex therapist is the right next step when the pattern looks situational, anxiety-linked or relational, or when the medical checks come back clear.
What treatment evidence exists
The consistent finding across the reviews is that treatment evidence for DE is thin. Abdel-Hamid and Ali describe the literature as confined to case reports, case series and small studies. Perelman (2016) notes that no regulatory agency anywhere has approved a drug for it, and Nguyen and colleagues (2024) report no standardised treatment plan.
Psychological and sex-therapy approaches. The reviews list sex education, cognitive behavioural therapy, masturbatory retraining, sensate focus (graded touch without a goal of orgasm), couples therapy, and anxiety-reduction methods including mindfulness and breathing. Abdel-Hamid and Ali conclude that these appear effective in case reports and case series but have not been properly evaluated in large studies. Perelman calls the good success rates reported by sex therapists exploratory, because published studies are small, uncontrolled and lack validated outcome measures. Evidence label: EMERGING.
Changing masturbation and stimulation. This is the most concrete part. In Perelman's Sexual Tipping Point model, a therapist helps a man reduce or alter solo masturbation, change his style (for example switching hands or position) so it approximates partnered stimulation, and keep a gap before partnered sex. Perelman suggests at least 72 hours without solo orgasm before a partnered encounter, which he calls arbitrary and based on experience. Nguyen and colleagues describe lower-risk changes such as more erogenous-zone stimulation, altered pressure and pace, vibrators and role play, agreed with the partner. Evidence label: EMERGING; sensible and low-risk, but not shown in controlled trials.
Vibration. Abdel-Hamid and Ali cite a study by Nelson and colleagues in which penile vibratory stimulation adequately treated 72 per cent of men with secondary delayed orgasm. That was an uncontrolled clinic series. Perelman notes that vibrators are rarely needed within psychosexual retraining but may help after prostate cancer treatment. Evidence label: EMERGING.
Adjusting medicines. When an antidepressant or other drug is the likely cause, Nguyen and colleagues say clinicians should work with the prescriber on reducing the dose or changing the medicine. Abdel-Hamid and colleagues (2016) note that for antidepressant-related DE, switching to another antidepressant such as bupropion, or adding cabergoline in men with raised prolactin, may be the most prudent option. This is a prescriber decision, not a self-help step.
Drugs that have been tried. No drug is approved for DE. Cabergoline and bupropion are the most studied. A retrospective review in a single andrology clinic, as summarised by Nguyen and colleagues, found that 87 of 131 men (66.7 per cent) reported subjective improvement in orgasm; longer treatment and concurrent testosterone therapy were associated with response. Abdel-Hamid and colleagues concluded there is weak scientific evidence that cabergoline could help some cases of delayed orgasm, and flag a risk of heart-valve problems seen with longer, higher-dose use in other conditions; any monitoring is a decision for the prescriber. For bupropion, they describe a series of ten non-depressed men with orgasmic delay, 70 per cent of whom improved, and a series of 19 men with lifelong DE in which bupropion was of limited benefit in about a quarter. These are small, uncontrolled studies. Both drugs have real side effects. Evidence label: weak EMERGING at best. No doses are given here because this is a prescriber's decision.
Where somatic, breath and mindfulness work fits
The honest position is that the DE reviews cited here report no trial of tantric, somatic or breath-based practice. What exists is a mechanism-level case. Perelman's model proposes that anxiety draws attention away from erotic cues. Practices that train attention toward bodily sensation, and that calm a keyed-up nervous system, plausibly address that. Both reviews list mindfulness and breathing among sex-therapy components, and sensate focus is meant to remove the demand for orgasm. Claims about any named tradition go beyond that. Evidence label: EMERGING at the level of mechanism; UNEVIDENCED for tantric or somatic programmes as a treatment for DE.
In practice, the realistic role is as an adjunct to a medical check and behavioural work, ideally alongside a sex therapist, and not a replacement for either. Be cautious of anything that promises a cure or involves stopping medication.
What is not supported
Several common claims lack support. That DE is always psychological, or always physical: Perelman (2016) puts it as neither "all in the head" nor purely physical, and one organic cause, a medicine, is potentially reversible. That pornography alone causes it: UNEVIDENCED. That DE means the partner is unattractive: Perelman wants partners taught that it is not all their fault. That a supplement fixes it: none is supported in the cited reviews. And that a cure rate can be quoted: effect sizes are not known.
Partner perspective
DE is often described as a men's problem, but partners carry a lot of it. Perelman (2016) writes that some partners initially enjoy long intercourse, but usually come to experience annoyance, soreness and the painful question of whether he really finds them attractive. Despite blaming themselves at first, partners frequently become angry at the perceived rejection, and some men fake orgasm to avoid that reaction. Men with DE, he reports, often feel "less of a man", so the pressure runs both ways.
Abdel-Hamid and Ali note that a patient's preference about the partner's involvement matters more to success than the partner attending every appointment. A general observation, not a research finding: naming the pressure on both sides and treating the problem as shared tends to lower the stakes of each encounter.
Who to see, and when
A GP is the starting point for nearly everyone, and the right call sooner rather than later if the change is recent, followed a new medicine or procedure, or comes with erection trouble, numbness, pain, or bladder or bowel changes (general guidance). A urologist or endocrinologist becomes relevant with specific findings or a history of pelvic surgery or radiotherapy. A sex therapist or psychologist with sexual-health training helps with the anxiety, masturbation, communication and relationship factors, alongside medical care. A somatic or breath practitioner may suit a man who wants an adjunct, as long as it does not displace the medical check. If you feel low or hopeless, tell your GP; low mood is both a cause and a consequence of sexual difficulty. If you are thinking about harming yourself, call 000 or Lifeline on 13 11 14 (Australia), 999 or Samaritans on 116 123 (UK), or 911 or 988 (US).